Welcome to our dedicated page for Amcor Plc SEC filings (Ticker: AMCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Amcor plc (NYSE: AMCR) SEC filings, offering detailed insight into the company’s regulatory reporting as a global packaging business serving consumer and healthcare markets. Through these documents, investors can review how Amcor describes its operations in flexible and rigid packaging, its segment structure, financing activities and governance matters.
Amcor’s current reports on Form 8-K include disclosures on significant corporate events. Examples include the completion of an all-stock merger with Berry Global Group, Inc., the identification of a core portfolio of consumer packaging and dispensing solutions for nutrition and health, and updates on integration progress and synergy targets. Other 8-K filings describe quarterly and annual financial results, where Amcor reports segment data for its Global Flexible Packaging Solutions and Global Rigid Packaging Solutions businesses.
Additional 8-K filings document capital markets and financing transactions, such as the issuance of guaranteed senior notes in various maturities and currencies, registered exchange offers for existing notes, and the creation of direct financial obligations under indentures and agency agreements. Amcor has also filed current reports detailing shareholder approvals at its annual general meeting, including the ratification of its independent registered public accounting firm, advisory votes on executive compensation and the approval of an amendment to its memorandum of association to effect a reverse stock split.
Proxy materials, including the definitive proxy statement on Schedule 14A, provide information on Amcor’s board composition, executive compensation programs, governance practices and shareholder proposals. Investors can use annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, to review more comprehensive discussions of the company’s business, risk factors and financial statements.
On Stock Titan, Amcor filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand items such as new debt issuances, reverse stock split details, merger-related disclosures, and voting outcomes from shareholder meetings. Real-time updates from EDGAR, combined with simplified explanations of forms like 10-K, 10-Q and 8-K, as well as access to information about guaranteed senior notes and other securities, make this page a useful starting point for analyzing AMCR’s regulatory history.
Amcor plc director reports small share sale to cover taxes. A director of Amcor plc filed a Form 4 disclosing the sale of 4,148 ordinary shares on 12/03/2025 at a price of $8.439 per share. The explanation states that the sale was used to cover the reporting person’s corresponding tax liability. Following this transaction, the reporting person beneficially owned 82,535 ordinary shares, held directly.
Amcor plc director reported a sale of ordinary shares in a Form 4 filing. On 12/03/2025, the reporting person sold 6,058 ordinary shares of Amcor at a price of $8.439 per share. After this transaction, the director beneficially owned 71,302 shares, held directly.
According to the explanation provided, the 6,058-share sale was used to cover the reporting person’s corresponding tax liability, resulting in 8,221 shares. No derivative securities transactions were reported in this filing.
Amcor plc reported insider equity activity by one of its directors. On December 2, 2025, the director acquired 9,317 ordinary shares through the vesting and settlement of restricted stock units, reported with transaction code "M." After this transaction, the director directly held 305,649 ordinary shares.
The filing also shows changes in derivative holdings. A block of 9,317 restricted stock units previously outstanding was settled for ordinary shares at an exercise price of $0, reducing those derivative holdings to zero. In a separate transaction on December 1, 2025, the director received a new grant of 19,907 restricted stock units, which carry no exercise price and are scheduled to vest on December 1, 2026. Each restricted stock unit represents a contingent right to receive one Amcor ordinary share upon vesting.
Amcor plc director reports equity award activity. A director of Amcor plc (AMCR) acquired 15,159 ordinary shares on 12/02/2025 through the vesting and settlement of previously granted restricted stock units, reported as a transaction code "M". Following this transaction, the director directly held 15,159 ordinary shares.
In addition, the director received a new grant of 19,907 restricted stock units on 12/01/2025. Each restricted stock unit represents a contingent right to receive one ordinary share of Amcor upon vesting, and this new award is scheduled to vest in full on 12/01/2026.
Amcor plc reported an insider equity transaction by a director. On 12/02/2025, the director exercised 14,279 restricted stock units (RSUs) into the same number of ordinary shares in a transaction coded "M". After this, the director beneficially owned 43,802 ordinary shares directly. The filing also shows a new award of 19,907 RSUs on 12/01/2025, scheduled to vest on 12/01/2026. Each RSU represents a contingent right to receive one Amcor ordinary share upon vesting.
Amcor plc director reported routine equity activity involving restricted stock units. On December 2, 2025, 9,317 restricted stock units vested and were settled into the same number of ordinary shares at an exercise price of $0, increasing direct ownership to 24,484 ordinary shares. The filing also shows indirect holdings of 1,297.75 ordinary shares through a spouse trust, which includes an additional 0.75 share acquired via a dividend reinvestment program, and 60,902 ordinary shares through the JTG Trust.
Separately, on December 1, 2025, the director received a new award of 19,907 restricted stock units, each representing a right to receive one ordinary share. These units are scheduled to vest on December 1, 2026, and are held directly. After these transactions, the director continues to hold a mix of vested ordinary shares and unvested restricted stock units tied to Amcor’s share performance.
Amcor plc reported an insider equity transaction by a director. On December 2, 2025, the director exercised 14,279 restricted stock units (RSUs), receiving the same number of ordinary shares. Each RSU represents a right to one ordinary share upon vesting. After this transaction, the director beneficially owned 103,246 ordinary shares directly.
On December 1, 2025, the director was also awarded a new grant of 19,907 RSUs, which are scheduled to vest in full on December 1, 2026. Following these transactions, the director held 19,907 RSUs in addition to the ordinary shares, all reported as directly owned. The transactions were reported on a Form 4 and reflect routine equity compensation activity rather than a change in control.
Amcor plc director reports restricted stock unit activity and share holdings. A director of Amcor plc (AMCR) converted 9,317 restricted stock units into the same number of ordinary shares on 12/02/2025 at an exercise price of $0. After this transaction, the director beneficially owns 396,727 ordinary shares directly and an additional 10,000 shares indirectly through a trust. The filing also shows a new award of 19,907 restricted stock units granted on 12/01/2025, which are scheduled to vest on 12/01/2026. Each restricted stock unit represents a contingent right to receive one Amcor ordinary share upon vesting.
Amcor plc reported an equity transaction by one of its directors. On December 2, 2025, the director exercised 9,317 restricted stock units, receiving the same number of ordinary shares and bringing their directly held ordinary shares to 86,683.
In a separate transaction dated December 1, 2025, the director was granted 19,907 new restricted stock units, each representing a contingent right to receive one ordinary share. These new units are scheduled to vest on December 1, 2026.
Amcor plc shareholder files notice to sell restricted shares under Rule 144. A holder of Amcor common stock plans to sell 6,058 shares through Fidelity Brokerage Services on or around
The notice states that the seller does not know of any undisclosed material adverse information about Amcor’s current or prospective operations, consistent with Rule 144 requirements.